Group A β-Hemolytic Streptococcus Meningitis: Clinical and Microbiological Features of Nine Cases by Sommer, Richard et al.
Group A b-Hemolytic Streptococcus Meningitis: Clinical and Microbiological
Features of Nine Cases
Richard Sommer, Peter Rohner, Jorge Garbino,
Raymond Auckenthaler, Raffaele Malinverni,
Daniel Lew, and Laurent Kaiser
From the Division of Infectious Diseases, University Hospital of
Geneva, Geneva, Switzerland
Group A b-hemolytic streptococcus (GAS) meningitis is a rare disease in adults. We conducted a
retrospective study to describe clinical and microbiological features of nine cases of GAS meningitis
in Switzerland. Of nine patients, six had neurosurgical conditions, and five had upper respiratory
tract infections. Eight cases were community-acquired. The outcome of GAS meningitis was
favorable; only one patient died of neurosurgical complications. No patient presented with toxic
shock syndrome. Serotyping failed to reveal a dominant strain, and genotyping revealed that two
strains carried the gene encoding the streptococcal pyrogenic exotoxin C and that one strain carried
the gene encoding the streptococcal pyrogenic exotoxin A. Our observations suggest that GAS
meningitis in adults is associated with neurosurgical conditions and/or an upper respiratory tract
infection.
During the last two decades, group A b-hemolytic streptococcus
(GAS) invasive disease has been observed with an increasing
frequency. It is associated with soft-tissue involvement, bactere-
mia, and streptococcal toxic shock syndrome (STSS) [1, 2]. Other
sites of involvement are the lungs, middle ear, joints, and bones.
Despite the ability of GAS to invade soft tissues, CNS infection
remains a rare event in adults. In recent studies describing invasive
GAS disease, meningitis was not mentioned [2–4]. In a MED-
LINE search of the world literature, we found 40 cases of GAS
meningitis, which occurred mostly in children. In an extensive
review, Chow and Muder [5] described only eight cases in adults.
Very little is known about the predisposing factors and clinical
features of GAS meningitis. The aim of our study was to identify
conditions associated with GAS meningitis and to analyze the
strains involved.
Patients and Methods
Cases were identified through results of CSF cultures per-
formed in all main Swiss hospitals from 1983 to 1998. Identi-
fication of GAS by CSF culture was the inclusion criterion.
Associated conditions, clinical features, and outcomes were
reported on standardized case report forms. GAS was identified
biochemically by using API 20 STREP Strips (bioMe´rieux,
Marcy l’Etoile, France), and streptococcal antigens were de-
termined by rapid antigen extraction and latex agglutination
testing (Slidex, Strepto-kit, bioMe´rieux).
If the original strain was available, serotyping and genotyp-
ing were performed. Serotyping was performed by the PHLS
Laboratory (London) according to standard procedures. Geno-
typing was carried out in the same laboratory by amplifying
streptococcal pyrogenic exotoxin A, B, or C with a multiplex
PCR [6].
Results
Nine cases of GAS meningitis were identified in five females
and four males; the median age of the patients was 37 years.
GAS meningitis was community-acquired in eight cases, and
case 1 occurred 18 days after discharge from the hospital (table
1). One patient was pregnant, one had HIV infection, and
another had ischemic heart disease. No chronic underlying
diseases were present in any other patient.
Clinical signs of CNS infection were present in all cases but
one. Organ failure or septic shock was not observed, and no
case met the criteria for STSS [7].
Six patients (67%) had prior or concomitant neurosurgical
conditions, four of whom had skull fractures. Three of these
patients had proven or highly probable CSF leaks. Four pa-
tients underwent neurosurgery: several years before, two; and
during hospitalization for meningitis, two.
Five patients also had ear, nose, and throat infections (table
1). All together, eight patients had histories or diagnoses of
frontobasilar skull fracture and/or ear, nose, and throat infec-
tion before the onset of GAS meningitis. Cerebral CT scans
were obtained for seven patients. Four of these scans showed
neurosurgical abnormalities. Results of CSF analyses are pre-
sented in table 1. All patients were treated with b-lactam
antibiotics. Outcomes were favorable for eight patients, and
one died several weeks later following surgery for a cerebral
abscess. Only one patient had mild residual left-hand paresis.
Blood cultures were performed in seven cases. Of these
cultures, three (for which specimens were obtained before
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antibiotic therapy was started) yielded GAS, and four (for
which specimens were obtained after therapy was started)
remained negative. All nine CSF strains were susceptible to
penicillin; six were available for characterization, serotyping,
and genotyping. M types were variable; the speC gene was
identified in two strains, and the speA gene was identified in
one strain (table 1).
Discussion
We describe the clinical and microbiological features of nine
sporadic cases of GAS meningitis in adults. Six patients had
neurosurgical conditions, mainly sequelae of skull fractures or
complications arising from neurosurgical procedures; three of
these patients with neurosurgical conditions and two additional
patients had bacterial upper respiratory tract infections. Apart
from one HIV-infected patient, no chronic underlying condi-
tion was present, thus suggesting that GAS meningitis can
occur in otherwise healthy adults.
Invasive GAS disease is often associated with STSS [3, 8].
In our series, three patients had associated bacteremia, and
none had soft-tissue infection, severe organ failure, or criteria
for STSS. These findings suggest that GAS meningitis is not a
complication of invasive GAS disease but rather follows in-
fection and/or colonization of the ear, nose, and throat sphere.
The fact that three patients had basilar skull fractures and one
other had undergone transsphenoidal surgery supports this hy-
pothesis. Upper respiratory tract infections, neurosurgical con-
ditions, and CSF leaks are well-known causes of acute bacterial
meningitis and streptococcal meningitis [5, 9–11]. These ob-
Table 1. Clinical features of and microbiological results for nine adults with GAS meningitis.
Patient no./year
of diagnosis,
age (y)
Associated
condition(s)
CSF analysis
Gram
staining
Cell count
(/mm3)
%
PMNs
Glucose level
(mmol/L)
Other site(s)
of GAS
identification M and T types
Pyrogenic
exotoxin
gene(s)
Therapy
(duration)
1 (1996), 38 Hypophysectomy
for Cushing’s
disease
Negative 575 83 2.8 None M6 and T6 B and C Pen (2 w)
2 (1995), 40 Frontobasilar
skull fracture,
CSF leak and
sinusitis
Cocci 1,700 87 4.5 None NA NA Ctri/Amp
then Pen
(2 w)
3 (1997), 40 HIV infection,
posttraumatic
subdural
hematoma,
otitis media
Cocci 456 93 5.11 Blood NT B Pen then
Ctri
(6 w)
4 (1990), 30 Chronic frontal
fistula after
frontobasilar
skull fracture
Cocci 25 14 NA Brain
abscess
M2 and T2/28 B Flox (3 w)
5 (1998), 15 Occipital skull
fracture 3 y
before and
suspicion of
CSF leak
Cocci 26,112 92 2.8 Blood NA NA Ctri then
Amox (3
w)
6 (1989), 17 Pharyngitis and
sinusitis,
jugular
phlebitis,
cavernous
thrombosis
Cocci 40,960 93 1.1 Throat and
conjunctiva
M1 and T1 A and B Ctri/Pen
(3 w)
7 (1983), 63 Otitis media and
mastoiditis,
ischemic heart
disease
NA 938 67 2.7 Mastoid
bone
PT4245 and T11 B Pen (4 w)
8 (1998), 63 Pharyngitis Cocci 28,500 98 NA Blood None and T28 B and C Pen/Cm
(4 w)
9 (1995), 30 Pregnancy Cocci 3,925 100 1.88 None NA NA Ctri (3 w)
NOTE. Amox 5 amoxicillin; Amp 5 ampicillin; Cm 5 clindamycin; Ctri 5 ceftriaxone; Flox 5 floxacillin; GAS 5 group A b-hemolytic streptococcus;
NA 5 not available; NT 5 nontypeable strain; Pen 5 penicillin; PMNs 5 polymorphonuclear cells.
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servations also suggest that patients carrying GAS in their
nasopharynx would probably benefit from antibiotic prophy-
laxis before surgical procedures.
The outcome, in comparison with the high mortality rate
observed in cases of invasive GAS disease, was favorable. A
similar outcome was also observed in previous case reports [5,
9]. The mortality rate associated with GAS meningitis also
appears to be lower than that associated with pneumococcal or
nosocomial meningitis.
Genotyping failed to reveal a dominant strain, and the M
types were variable. All strains analyzed were found to
contain the speB gene, which is consistent with findings of
previous studies showing that .90% of GAS strains produce
the speB gene [12, 13]. However, two strains were found to
contain the speC gene, and only one had the speA gene.
These results are surprising since most previous studies on
invasive GAS disease reported high incidences of strains
producing the speA gene [12]. Our investigations suggest
that production of the speA gene is not a determinant in
causing GAS meningitis but more likely is due to locally
invasive strains. Recent reports on the virulence factors
produced by GAS support this hypothesis [14].
Virulence factors such as the fibronectin-binding proteins
(SfbI) and the F1 protein contribute to the increased adherence
of GAS strains, which may explain the potential of this micro-
organism to locally invade host tissues [14]. In addition, the
fact that two strains contained the speC gene suggests that in
some instances exotoxin C may have been a virulent factor
promoting this streptococcal disease. The speC gene is a vir-
ulent factor that has already been associated with streptococcal
disease [15]. Several other toxins or virulence factors including
the streptococcal superantigen are also associated with invasive
streptococcal diseases. In the present study, we did not inves-
tigate if the streptococcal superantigen was present.
Our observations suggest that GAS meningitis in adults is
not a complication of sustained bacteremia but rather is asso-
ciated with neurosurgical conditions and/or upper respiratory
tract infections. GAS meningitis does not seem to be associated
with STSS or strains producing the speA gene. Adults with
GAS meningitis have a favorable prognosis if antibiotic ther-
apy is promptly initiated.
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